Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
56.50
-1.23 (-2.13%)
At close: Mar 9, 2026, 4:00 PM EDT
54.50
-2.00 (-3.54%)
After-hours: Mar 9, 2026, 7:08 PM EDT
Structure Therapeutics Market Cap
Structure Therapeutics has a market cap or net worth of $4.00 billion as of March 9, 2026. Its market cap has increased by 198.85% in one year.
Market Cap
4.00B
Enterprise Value
2.56B
1-Year Change
198.85%
Ranking
Category
Stock Price
$56.50
Market Cap Chart
Since the IPO on February 3, 2023, Structure Therapeutics's market cap has increased from $548.82M to $4.00B, an increase of 629.30%. That is a compound annual growth rate of 90.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 4.09B | -14.95% |
| Dec 31, 2025 | 4.81B | 209.65% |
| Dec 31, 2024 | 1.55B | -22.02% |
| Dec 29, 2023 | 1.99B | 262.83% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Terns Pharmaceuticals | 4.66B |
| Amicus Therapeutics | 4.50B |
| TG Therapeutics | 4.32B |
| Ligand Pharmaceuticals | 4.03B |
| Crinetics Pharmaceuticals | 4.00B |
| Viking Therapeutics | 3.81B |
| Centessa Pharmaceuticals | 3.79B |
| ACADIA Pharmaceuticals | 3.78B |